4//SEC Filing
INVESTOR GROWTH CAPITAL LTD 4
Accession 0001181431-10-001309
CIK 0001070336other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 5:33 PM ET
Size
9.3 KB
Accession
0001181431-10-001309
Insider Transaction Report
Form 4
INVESTOR AB
10% Owner
Transactions
- Sale
Common Stock
2009-12-31$3.21/sh−56,000$179,732→ 2,119,714 total(indirect: See Footnote) - Sale
Common Stock
2009-12-31$3.21/sh−39,200$125,812→ 1,483,810 total
Footnotes (3)
- [F1]39,200 shares of Common Stock, par value $0.001 (the "Common Stock"), were sold by Investor Growth Capital Limited and 16,800 shares of Common Stock were sold by Investor Group, L.P. The shares of Common Stock reported in Column 5 are held directly by Investor Growth Capital Limited and Investor Group, L.P. Investor Growth Capital Limited is an indirect wholly-owned subsidiary of Investor AB. Investor Group, L.P. is a limited partnership of which Investor AB is the indirect general partner. Investor AB may be deemed to beneficially own the securities held by Investor Growth Capital Limited and Investor Group, L.P. Investor AB disclaims beneficial ownership of such securities except to the extent of its pecuniary interest in such securities.
- [F2]These shares of Common Stock were sold by Investor Growth Capital Limited.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.13 to $3.24. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Documents
Issuer
ACHILLION PHARMACEUTICALS INC
CIK 0001070336
Entity typeother
Related Parties
1- filerCIK 0001237710
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 5:33 PM ET
- Size
- 9.3 KB